Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. - Wikidata - awgldk - TriplyDB

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

http://www.wikidata.org/entity/Q34450913

about

Wine polyphenols: potential agents in neuroprotection Medications and Diet Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity Polyphenolic Antioxidants and Neuronal Regeneration Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia Cellular and molecular effects of resveratrol in health and disease Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer's disease Sirtuin1 and autophagy protect cells from fluoride-induced cell stress SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential Resveratrol derived butyrylcholinesterase inhibitors.Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells Regulation of histone acetylation in the hippocampus of chronically stressed rats: a potential role of sirtuins.Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.Therapeutic potential of resveratrol in Alzheimer's disease Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Role of the ubiquitin proteasome system in Alzheimer's disease.CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants.Promoting successful cognitive aging: a comprehensive review.Erratum: Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway.A genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression.Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticity Resveratrol and Alzheimer's disease: message in a bottle on red wine and cognition.

P2860

Q21284967-A92F8824-D753-452E-A136-1DD7A02FE3AB Q22242806-464428B2-BF3E-44A8-94FF-FEEFA4B8D24C Q24294322-4271E107-0434-4E89-85BC-0F822E865F7A Q24336362-D46BC8FE-2056-42F6-8FFB-82062EFB078B Q24617577-67298DEE-2157-4F03-9290-66B0ED8F4B78 Q24618313-58E3B98B-28FD-4185-9426-B4D074DABDEF Q24657235-F17C9E3C-4FBE-49DC-AAF2-B6ECD9264D83 Q26745945-685C7E49-2BB0-49B8-B030-DCC1DFA3FC54 Q26747742-9F33E8B2-B405-4B4B-BFA9-2A4D4BC9EFD6 Q26749321-A536013D-9D83-4BF5-8930-7ACD6218CC7F Q26800907-C7C69010-0DB7-45C1-A3F2-299DE6CDC3AD Q26800956-4EE215E8-4810-45AA-B641-46C0F6685C28 Q26830740-9B1802AC-99A7-44E1-B037-4AFCDD0392EC Q26852205-2FB7CD9C-FA61-4673-8D0C-168BF5B0B15B Q27021700-4AF356CE-F364-4FD6-95D0-A4D43BB188DD Q27026884-90C3C2FF-9810-4C45-989F-29C426260FE1 Q28071699-58DD2B79-C5CC-4592-94EA-FC9FFD2DF758 Q28222555-F7260026-A651-4E6A-881E-3677F1004385 Q28252560-FD4C7049-0E61-49E2-8181-64226B4F72BA Q28259585-64CDE9A3-4703-4D19-ADC1-CFF8424911A3 Q28394101-C9ECBFD5-A6CC-4AC9-8DBE-5994E1B132AC Q28572908-6608770C-1303-46A3-B518-1B893A3A6EA5 Q28583941-B414F802-729D-4ECE-B52F-93F2988FE377 Q28749173-921DEB7D-CE22-416B-AB54-F6A7F3D3041E Q29994589-DDC86718-C369-49BD-98D5-41AFEC9C95FD Q30317807-13A1DCF2-C544-4FFB-9AF4-56A8FFC1B621 Q30363322-22A015D5-D0AC-4A94-9E58-6FCEB8FE4294 Q30428450-BE868B8C-3AD0-4AC5-970A-11977364B833 Q30492766-43040AFA-674B-41E7-B321-FDE120C621E5 Q30855117-1F212085-0F41-4F27-BC93-CC7FEBB6BEA8 Q31047131-2A330785-4ECE-4C53-9E96-CB72FD574412 Q33307872-43A104C4-CFB0-47AD-A8FE-99951BAE1217 Q33334431-F9DBB691-4AD3-4AB0-8C46-88688B0A0E49 Q33360912-CEEBDF29-9845-480D-AF2F-2AF439375AA6 Q33544151-0F015C3E-0F7E-410C-A5EC-B04C6D4A6B76 Q33560898-8799A0B7-6695-4169-92A6-931216461075 Q33578980-74652498-2EF9-4C35-B46A-27C2925F9783 Q33602768-CC6FFBD7-25A0-472B-96E7-70F51FC6AD16 Q33611723-0452CFC1-892C-4307-B70F-C37C108ED267 Q33646957-EB2AA07C-1D7F-4923-BF66-0A3AD01644E1

P2860

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

http://www.wikidata.org/entity/Q34450913

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@ast

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@en

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@nl

type

label

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@ast

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@en

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@nl

prefLabel

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@ast

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@en

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@nl

P1433

Q34450913-AE12347C-6FE7-4316-AB7E-8B4181ABDD4B

P1476

Q34450913-E61F021F-3E66-43A5-BDDB-8B536119EAD5

P2093

Q34450913-12D55F6A-2F03-4568-8D85-F3A98FFC2AC2

Q34450913-DA35B72D-978C-4455-BE7E-6BE33A61E80B

Q34450913-DABFCCC3-5E26-4E42-BF18-1AEFB265BFF6

P304

Q34450913-1439A063-653A-4645-B93E-A0BE1AD5B2B6

P31

Q34450913-B8173B9A-BA17-420E-BFB3-2E5B9D444E42

P356

Q34450913-13BC629B-5DA8-46E3-85BC-25E26BB83C0C

P407

Q34450913-84661352-E835-4CC2-B8A8-8569230257F1

P433

Q34450913-C95E7282-02D2-445D-80C0-8912FBD7E604

P478

Q34450913-D45EF53A-DBBD-46D4-B641-A4B0F1F92C0F

P577

Q34450913-10034D27-FF96-4426-82F6-A6E277B9BAA0

P698

Q34450913-1ABE58B0-722C-497E-99DA-0BF554B45EF4

P921

Q34450913-FEB4DC2E-01E8-4B06-84C1-07D22AB0A332

P356

P1433

Journal of Biological Chemistry

P1476

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

@en

P2093

Haitian Zhao

http://www.w3.org/2001/XMLSchema#string

Peter Davies

http://www.w3.org/2001/XMLSchema#string

Philippe Marambaud

http://www.w3.org/2001/XMLSchema#string

P304

37377-37382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M508246200

http://www.w3.org/2001/XMLSchema#string

P407

P433

45

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16162502

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease